Setting corporate strategy and investment priorities requires relentless attention to the changing landscape internally and externally. Navigant's Life Sciences enterprise strategy consulting team helps life sciences companies identify the areas that are best suited for investment.
We use objective and fact-based assessments and prioritization of company portfolios, geographic opportunities, white space analyses, and acquisition candidates. As a result, organization members share a common language, common measures, and a systematic approach. So, cross-functional teams move forward collaboratively with a mutual understanding of what success looks like and how to achieve it.
To support business unit leadership, we uncover promising opportunities for growth, balance risk and return, prioritize pipeline investments that support strategic goals, and help squeeze maximum value from de-prioritized projects.
For corporate leadership, we help identify platforms best aligned for three-, five-, and 10-year growth planning, down to the specific allocation of resources and investments to position organizations for success. Our solutions include:
Strategic Market Assessment
Business development and licensing
Target search and prioritization
Due diligence/revenue forecasting (external asset assessment)